Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065865
Filing Date
2015-11-16
Accepted
2015-11-16 15:10:19
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v424360_10q.htm 10-Q 375501
2 EXHIBIT 31.1 v424360_ex31-1.htm EX-31.1 10419
3 EXHIBIT 32.1 v424360_ex32-1.htm EX-32.1 4585
  Complete submission text file 0001144204-15-065865.txt   3802573

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ppch-20150930.xml EX-101.INS 622284
5 XBRL TAXONOMY EXTENSION SCHEMA ppch-20150930.xsd EX-101.SCH 47229
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ppch-20150930_cal.xml EX-101.CAL 34402
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ppch-20150930_def.xml EX-101.DEF 293861
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ppch-20150930_lab.xml EX-101.LAB 291296
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ppch-20150930_pre.xml EX-101.PRE 317844
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 151233760
SIC: 2834 Pharmaceutical Preparations